| Analysis | Samples | Factors | Units |
|---|---|---|---|
| Reversed phase POSITIVE ION MODE | ncB1 | Treatment:BPA | Peak intensity |
| Reversed phase POSITIVE ION MODE | ncB2 | Treatment:BPA | Peak intensity |
| Reversed phase POSITIVE ION MODE | ncB3 | Treatment:BPA | Peak intensity |
| Reversed phase POSITIVE ION MODE | ncB4 | Treatment:BPA | Peak intensity |
| Reversed phase POSITIVE ION MODE | ncB5 | Treatment:BPA | Peak intensity |
| Reversed phase POSITIVE ION MODE | ncV1 | Treatment:vehicle | Peak intensity |
| Reversed phase POSITIVE ION MODE | ncV2 | Treatment:vehicle | Peak intensity |
| Reversed phase POSITIVE ION MODE | ncV3 | Treatment:vehicle | Peak intensity |
| Reversed phase POSITIVE ION MODE | ncV4 | Treatment:vehicle | Peak intensity |
| Reversed phase POSITIVE ION MODE | ncV5 | Treatment:vehicle | Peak intensity |
| Reversed phase NEGATIVE ION MODE | ncB1 | Treatment:BPA | Peak intensity |
| Reversed phase NEGATIVE ION MODE | ncB2 | Treatment:BPA | Peak intensity |
| Reversed phase NEGATIVE ION MODE | ncB3 | Treatment:BPA | Peak intensity |
| Reversed phase NEGATIVE ION MODE | ncB4 | Treatment:BPA | Peak intensity |
| Reversed phase NEGATIVE ION MODE | ncB5 | Treatment:BPA | Peak intensity |
| Reversed phase NEGATIVE ION MODE | ncV1 | Treatment:vehicle | Peak intensity |
| Reversed phase NEGATIVE ION MODE | ncV2 | Treatment:vehicle | Peak intensity |
| Reversed phase NEGATIVE ION MODE | ncV3 | Treatment:vehicle | Peak intensity |
| Reversed phase NEGATIVE ION MODE | ncV4 | Treatment:vehicle | Peak intensity |
| Reversed phase NEGATIVE ION MODE | ncV5 | Treatment:vehicle | Peak intensity |
Return to study ST001311 main page
Download data matrix(Lipid expression in liver after early lifer exposure to an endocrine disruptor at 70 days postnatal (part-II) Reversed phase POSITIVE ION MODE)
Download data matrix(Lipid expression in liver after early lifer exposure to an endocrine disruptor at 70 days postnatal (part-II) Reversed phase NEGATIVE ION MODE)
- Metabolomics Workbench
|